These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21652710)

  • 1. The P2Y(2) nucleotide receptor mediates tissue factor expression in human coronary artery endothelial cells.
    Ding L; Ma W; Littmann T; Camp R; Shen J
    J Biol Chem; 2011 Jul; 286(30):27027-38. PubMed ID: 21652710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic P2Y2 Receptor Control of Tissue Factor Transcription in Human Coronary Artery Endothelial Cells: NEW AP-1 TRANSCRIPTION FACTOR SITE AND NEGATIVE REGULATOR.
    Liu Y; Zhang L; Wang C; Roy S; Shen J
    J Biol Chem; 2016 Jan; 291(4):1553-1563. PubMed ID: 26631725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1).
    Seye CI; Yu N; González FA; Erb L; Weisman GA
    J Biol Chem; 2004 Aug; 279(34):35679-86. PubMed ID: 15175347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells.
    Seye CI; Yu N; Jain R; Kong Q; Minor T; Newton J; Erb L; González FA; Weisman GA
    J Biol Chem; 2003 Jul; 278(27):24960-5. PubMed ID: 12714597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of P2Y6 receptor in cultured spinal microglia induces the production of CCL2 through the MAP kinases-NF-κB pathway.
    Morioka N; Tokuhara M; Harano S; Nakamura Y; Hisaoka-Nakashima K; Nakata Y
    Neuropharmacology; 2013 Dec; 75():116-25. PubMed ID: 23916475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases.
    Santiago-Pérez LI; Flores RV; Santos-Berríos C; Chorna NE; Krugh B; Garrad RC; Erb L; Weisman GA; González FA
    J Cell Physiol; 2001 May; 187(2):196-208. PubMed ID: 11267999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells.
    Ding Y; Gao ZG; Jacobson KA; Suffredini AF
    J Pharmacol Exp Ther; 2010 Dec; 335(3):693-702. PubMed ID: 20826566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
    Moore DJ; Chambers JK; Murdock PR; Emson PC
    Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular ATP activates the PLC/PKC/ERK signaling pathway through the P2Y2 purinergic receptor leading to the induction of early growth response 1 expression and the inhibition of viability in human endometrial stromal cells.
    Chang SJ; Tzeng CR; Lee YH; Tai CJ
    Cell Signal; 2008 Jul; 20(7):1248-55. PubMed ID: 18434089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.
    Raqeeb A; Sheng J; Ao N; Braun AP
    Cell Calcium; 2011 Apr; 49(4):240-8. PubMed ID: 21414662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UTP induces vascular responses in the isolated and perfused canine epicardial coronary artery via UTP-preferring P2Y receptors.
    Matsumoto T; Nakane T; Chiba S
    Br J Pharmacol; 1997 Dec; 122(8):1625-32. PubMed ID: 9422807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP.
    Hou M; Möller S; Edvinsson L; Erlinge D
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2064-9. PubMed ID: 10978250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration.
    Pillois X; Chaulet H; Belloc I; Dupuch F; Desgranges C; Gadeau AP
    Circ Res; 2002 Apr; 90(6):678-81. PubMed ID: 11934835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y(2) receptor-mediated proliferation of C(6) glioma cells via activation of Ras/Raf/MEK/MAPK pathway.
    Tu MT; Luo SF; Wang CC; Chien CS; Chiu CT; Lin CC; Yang CM
    Br J Pharmacol; 2000 Apr; 129(7):1481-9. PubMed ID: 10742305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of ATP from Schwann cells in response to uridine triphosphate.
    Liu GJ; Werry EL; Bennett MR
    Eur J Neurosci; 2005 Jan; 21(1):151-60. PubMed ID: 15654852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells.
    Huwiler A; Wartmann M; van den Bosch H; Pfeilschifter J
    Br J Pharmacol; 2000 Feb; 129(3):612-8. PubMed ID: 10711362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.
    Guha M; O'Connell MA; Pawlinski R; Hollis A; McGovern P; Yan SF; Stern D; Mackman N
    Blood; 2001 Sep; 98(5):1429-39. PubMed ID: 11520792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways.
    Shen J; DiCorleto PE
    Circ Res; 2008 Feb; 102(4):448-56. PubMed ID: 18174464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cytokine-mediated JNK signalling by purinergic P2Y
    Ng PY; McIntosh KA; Hargrave G; Ho KH; Paul A; Plevin R
    Cell Signal; 2018 Nov; 51():59-71. PubMed ID: 30076967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
    Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T
    Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.